Festival-goers across the North Island experienced a muddy night as torrential rain drenched campsites. Video / Tyler Tantin A group of Rhythm and Vines festival-goers were forced to trek through the ...

When you sit down with a game, you make a pact with it: you’ll push the buttons, and it will show you what happens when you do. A lot of games don’t really care to interrogate what that means, to use ...

Axcelis Technologies is upgraded to BUY after Q3FY25 revenue beat and signs of business stabilization. ACLS announced an all-stock merger with Veeco to diversify end markets and reinforce non-China ...

Harvard will hold its 40th Cultural Rhythms celebration next spring without major changes to programming despite the closure of the office that previously hosted the annual festival, according to ...

Even for an artist so adept at reinvention, Carrier’s run of EPs leading up to Rhythm Immortal was astounding. He developed an original techno language with an ancient junglist script. A mixtape ...

Paige mixes golf with a playful beat, showing that sports can be fun and stylish. Attempted carjacking of a soccer coach goes wrong; 1 man in custody FBI investigates hunting stand with sight line to ...

Axcelis Technologies, Inc. and Veeco Instruments Inc. are merging in a $4.4 billion all-stock deal to create a diversified semiconductor equipment company. The merger aims to broaden product offerings ...

What makes music unique, unlike other forms of expression or communication? I suspect most people could put together a personal list of several things. But among the most important have to be the ways ...

We’ve been force-fed the idea for decades: The secret to success is routine. Wake up at 5 a.m., step into a punishing physical routine, follow a strict schedule and stick to your plan no matter what.

When a patient's condition changes, nurses are usually the first to notice it. Every second counts when there is a high risk of cardiac arrest, stroke, or respiratory failure. Advanced Cardiovascular ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. A phase 2 trial of the biotech’s next-generation oral candidate hit its primary endpoint, sending the stock ...